skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Get insight into Scrip reports with this complimentary article pack

Supercharge your market intelligence with Commercial Strategy and Scrip:

  • Pharmapremia gives you access to Likelihood of Approval, Probability of Technical Success, and clinical trial duration metrics to help you benchmark and make informed decisions about drug pipeline prioritization, partnerships, and acquisitions.

  • Biomedtracker’s best-in-class trial data and Probability of Technical Success (PTS) data helps you predict clinical and regulatory risk for pharmaceutical agents.

  • Datamonitor Healthcare provides access to primary research studies with physicians, payers and key opinion leaders, and secondary research vetted by skilled analysts to better assist you in your forecasts.

  • Scrip completes the picture by delivering daily insights from licensing to clinical trials to competitor activity to stay current on business developments in your market.
 
Scrip_Article_pack_Cover_Image

Read also

  • Biomedtracker: follow the drug development process , Datamon...

    Key potential drug launches 2020

    Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

    Topics Drug approval Drug review Drug development landscape

  • Datamonitor Healthcare: data analysis and insight

    Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

    By Amanda Micklus

    As more regenerative medicine products approach clinical testing and commercialization, seize this opportunity to hear detailed insights and industry best practices from preeminent sector experts. You’ll gain a deep understanding of numerous nurdles unique to bringing durable, curative therapies to patients in need.

    Topics Cell and gene therapy

  • Datamonitor Healthcare: data analysis and insight

    mHealth and Research in Oncology

    The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices”. In the last decade, the health sector has seen a substantial rise in the number of mHealth apps, many of which are designed to assist users in weight reduction and diabetes management. In 2016, there were 79,000 apps available in the Health & Fitness category in the Google and Apple stores. However, the implementation of mHealth in oncology is lagging, and there are comparatively few available apps. There is a need for the development of more mHealth apps in oncology settings considering the increasing disease burden and potential clinical benefit. 

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: